Clinical Trial Update: A Study to Evaluate the Safety and Use of Human Rhinovirus in Healthy and Asthmatic Participants (MK-0000-218) [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating safety and use of a human rhinovirus in healthy and asthmatic participants; completed with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• MK-0000-218

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Asthma | Phase 1 | Status: COMPLETED | Results posted: 2017-03-13